3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Stomach Neoplasms
140
Esophageal Neoplasms
71
Pancreatic Neoplasms
42
Esophageal Squamous Cell Carcinoma
26
Carcinoma, Non-Small-Cell Lung
24
Adenocarcinoma Of Esophagus
23
Breast Neoplasms
18
Neoplasms
15
Neoplasm Metastasis
15
Colorectal Neoplasms
15
Prostatic Neoplasms
11
Ovarian Neoplasms
9
Melanoma
9
Squamous Cell Carcinoma of Head and Neck
8
Lung Neoplasms
8
Adenocarcinoma
8
Sarcoma
7
Colonic Neoplasms
7
Biliary Tract Neoplasms
7
Small Cell Lung Carcinoma
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Carcinoma, Renal Cell
6
Urinary Bladder Neoplasms
5
Gastrointestinal Neoplasms
5
Gallbladder Neoplasms
5
Carcinoma, Hepatocellular
5
Uterine Cervical Neoplasms
4
Salivary Gland Neoplasms
4
Rectal Neoplasms
4
Head and Neck Neoplasms
4
Interventions
pembrolizumab
3
Nivolumab
2
tislelizumab
1
Trastuzumab
1
Tablets
1
Specimen Handling
1
Quality of Life
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Immunotherapy
1
Imatinib Mesylate
1
Drug Therapy
1
Docetaxel
1
Cyclophosphamide
1
Combined Modality Therapy
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Biological Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Adenoid Cystic
×
Docetaxel
×
Gastrointestinal
×
Clear all
NCT04140526
2025-05-23
PRESERVE-001
OncoC4, Inc.
Phase 1/2
Active not recruiting
733 enrolled